BGLC

BIONEXUS GENE LAB CORP

BGLC·090628306·US·Common Stock·Basic Materials - Specialty Chemicals-Activist

BGLC (BIONEXUS GENE LAB CORP) is held by 2 institutional investors as of Q2 2026. Largest holders: UBS Group AG ($197), HRT FINANCIAL LP ($27). Net institutional sentiment: Mixed.

2
Holders
$224
Total Value
33% (3)
Consensus
1 buying - 2 selling
13F: Insider & Congress: Updated regularly
BGLC

Smart Money Verdict

View all
Loading verdict
Held by 2 funds

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Aug 14, 2026 · Activists Aug 14, 2026 · Congress none

ActivistTLTan Lee Su-Leng11.5%Aug 14, 2026
InsiderCFChong Set FuiVest 97K shAug 13, 2026
InsiderYKYap Chee KeongVest 32K shAug 13, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
101(-56.3%)$1970.0%-43.48%
0
New
14,283$270.0%-26.67%
17
Exited
0(-100.0%)$20.0%-22.92%
0
BGLCBGLCBIONEXUS GENE LAB CORP

Other Basic Materials stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used